Reoperation After Pancreaticoduodenectomy
Study Details
Study Description
Brief Summary
The aim of this study is to outline the incidence of early and late reoperation after PD, examine the risk factors for early surgical intervention and its impact on the surgical outcome, hospital stay, diseases recurrence and patient survival, address variable indications for late readmission and reoperation after PD and its impact on patient survival and disease recurrence.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
This is a retrospective cohort study of all patients who underwent PD for periampullary tumors in Gastrointestinal Surgical Center (GISC), Mansoura University, Egypt in the period between 2000 and 2018.The exclusion criteria included any patients with locally advanced periampullary tumor, metastases, patients with advanced liver cirrhosis (Child B or C), malnutrition, or coagulopathy.
Patient data were recorded in a prospectively maintained database. Preoperative variables included; age, sex, body mass index, patients' symptoms and signs, laboratory tests, tumor markers and preoperative biliary drainage. Intraoperative variables included; liver status, tumor size, pancreatic duct diameter, texture of the pancreas, operative time, blood loss, pancreatic reconstruction method and blood transfusion. Postoperative variables included postoperative complications, drain amylase, liver function, day to resume oral feeding, postoperative stay, re-exploration, hospital mortality, postoperative pathology, and surgical safety margins.
Data regarding reoperation included incidence, male to female ratio, hospital stay, interval to reoperation, number of explorations, indication of reoperation and surgical management, and postoperative outcome in terms of morbidity and hospital stay. Follow-up was carried out one week postoperatively, 3 months, 6 months and then after one year. The minimum duration of follow up was 2 years. Follow up was done by thorough history taking, clinical examination and abdominal CT in case of suspicious lesions on pelvi-abdominal ultrasound.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Reoperation group The group of patients who underwent pancreaticduodenectomy for management of periampullary tumors and required surgical reintervention afterwards for management of procedure-related complications as pancreatic fistula, bleeding, abdominal collection, biliary fistula, gastric fistula. |
Procedure: Surgical re-interventionafter pancreaticoduodenectomy
Mandatory surgical management of complications after pancreatico-duodenectomy through peritoneal lavage, draiange, repair of fistula, completion pancreatectomy, control of bleeding, bowel resection, and feeding jejunostomy.
|
| No reoperation group The group of patients who underwent pancreaticoduodenectomy for management of periampullary tumors and did not require surgical reintervention. |
Procedure: Surgical re-interventionafter pancreaticoduodenectomy
Mandatory surgical management of complications after pancreatico-duodenectomy through peritoneal lavage, draiange, repair of fistula, completion pancreatectomy, control of bleeding, bowel resection, and feeding jejunostomy.
|
Outcome Measures
Primary Outcome Measures
- Patient survival [2-20 years after surgery]
The duration between surgical intervention to patient death
- Tumor recurrence [2-20 years]
Duration between surgery and recurrence of periampullary tumors based on radiological or endoscopic investigations.
Secondary Outcome Measures
- Hospital stay after reoperation [10-90 days after reoperation]
duration between reoperation surgery to discharge from hospital
- Morbidity after reoperation [10-90 days after reoperation]
complications after reoperation including intr- or extra-luminal hemorrhage, pancreatic or gastric fistula, biliary leakage, thromboembolic diseases, and wound infection
- Risk factors for surgical reoperation [Before surgical intervention]
Factors that increase the probability that the patient undergoing pancreaticoduodenectomy would be at higher risk for reoperation
Eligibility Criteria
Criteria
Inclusion Criteria:
- all patients who underwent pancreaticoduodenectomy for periampullary malignant lesions in the duration between January 2000 and May 2018
Exclusion Criteria:
- Pancreaticoduodenectomy performed for benign tumors, recurrent malignant tumors, chronic pancreatitis, or inflammatory strictures were excluded from the study.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Mansoura University
Investigators
- Study Director: Ayman El Nakeeb, md, Professor of Surgery, Gastrointestinal Surgical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- R.20.04.819